9342-8530 Quebec Inc DGCRF

RE: What happened at the AGM..

[ready2go1]

I am looking forward to hearing some of the thoughts from the meeting but I wanted to add that Gen-Probe has kept CUR in the dark over the years when it comes to their plans for PCA3.
     We were close to finishing even on the day and I expect some additional details from CUR in terms of their upcoming plans for the lab. That should help with the move but the jumps will come with additional news from Gen-Probe in respect to pca3. We can already see that interest on the board has dropped off and I would like to see the U.S. buyers stay active on Friday with a positive open. Regardless of what happens in the next few weeks, we will have a nice run with news of the completion of the FDA trial and another nice run when GPRO reports that they have submitted for approval.
    By the way Bloom Burton who asked a question on the call, was part of the group of companies that were helping CUR raise money prior to JS cx the offering. I had a chance to speak with BB several times during that period and they spoke very highly about CUR and mentioned that they had a number of wealthy clients who were ready to invest prior to the deal being taken off the table (I would not have expected them to say anything else but they were excited for pca3 and what it would mean for this company.)
PCA3 is on tract to make a difference, especially with all the psa problems, and CUR is there to collect the rewards.
     Still looking for $2.00 in the near term